Matthew Kropp

Matt Kropp is a core member of the Marketing, Sales & Pricing, Social Impact, and Technology, Media & Telecommunications practices at Boston Consulting Group. He focuses on leveraging generative AI t(Gen AI) to create competitive advantage for clients across industries, and driving growth for SaaS companies through pricing strategy.

Matt has experience in: GenAI strategy; use-case build and transformation programs; B2B pricing strategy for tech, software, semiconductors, and industrial goods; digital transformation including cloud transformation; digital product innovation; the future of transportation and logistics; and large-scale business transformations.

Before joining the firm, Matt spent nine years as an entrepreneur building and running several technology consulting firms, a medical informatics software company, and a digital freight marketplace. He has served on the boards of Transplant Connect, a SaaS platform managing EMRs for 80% of organs transplanted in the US, and North Bridge Academy, a non-profit independent school in Marin County dedicated to teaching students with dyslexia.

AREAS OF EXPERTISE

EDUCATION

MBA, The Wharton School, University of Pennsylvania
BS, Aerospace Engineering, University of California, Los Angeles

Publications and Videos

What’s Possible: GenAI and Customer Service

Customer interactions with brands will soon be transformed by a new breed of conversational chatbots offering no wait times, 24/7 access, and 100% recall of support information—at cost savings up to 80 percent.

How CMOs Are Succeeding with Generative AI

GenAI technology is already enhancing marketing efficiency and productivity. Managed responsibly, it can positively reshape the role and influence of the CMO.

Getting Ahead of Disruptions in Chip Supply Chains

Uncertainty looks to be the new norm for the semiconductor industry. We outline strategies to help chip customers smooth out this volatility and gain a competitive edge.

Why Your Organization Needs Sustainable Software

Your digital infrastructure probably generates more carbon emissions than you think—and AI may make it worse. It’s time for sustainable software.

Inflation Is Forcing B2B CEOs to Rethink Pricing

Rather than see B2B inflation as a dire threat, companies should view it as an ideal opportunity to make long-overdue changes to pricing practices. The attention of senior leaders will never be more focused on pricing than it is right now.

Why BCG is Becoming Bionic and Why Your Company Should Too

To those of us of a certain age, the word “bionic” conjures an image of Lee Majors running in slow motion, foiling bad guys with superhuman strength. To those of us of a certain age, the word “bionic” conjures an image of Lee Majors running in slow motion, foiling bad guys with superhuman strength.

The $1T Impact of Ignoring Dyslexia

Dyslexia is the trillion-dollar problem we don’t know we have.

How to Price—and Sell—in a Pandemic

Revenues are down and will likely remain so for the rest of the year. But don’t panic. With a systematic day-to-day tactical response, companies can survive the crisis and thrive in the rebound.

Is Your Sales Org Ready for the (Covid) Fight?

By now we are all familiar with the Covid-19 battle stages: Flatten the curve of new infections now, Fight to keep new infections low while we reopen By now we are all familiar with the Covid-19 battle stages: Flatten the curve of new infections now, Fight to keep new infections low while we reopen.

B2B Pricing in the Time of COVID-19

Coronavirus has thrown markets and business into chaos. Read our five powerful strategies to manage your pricing through the crisis.

Silicon Valley Could Change the Game on Climate—Will They?

There is no topic of greater global importance today than climate change. We all know the science and the dire consequences of failing to act, but whaThere is no topic of greater global importance today than climate change. We all know the science and the dire consequences of failing to act, but what might be less known are the reasons for optimism.